company background image
1951 logo

Jinxin Fertility Group SZSC:1951 Stock Report

Last Price

HK$2.94

Market Cap

HK$8.1b

7D

1.0%

1Y

7.7%

Updated

07 May, 2025

Data

Company Financials +

Jinxin Fertility Group Limited

SZSC:1951 Stock Report

Market Cap: HK$8.1b

1951 Stock Overview

An investment holding company, provides assisted reproductive services (ARS) in China and the United States. More details

1951 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance1/6
Financial Health3/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Jinxin Fertility Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Jinxin Fertility Group
Historical stock prices
Current Share PriceHK$2.94
52 Week HighHK$4.64
52 Week LowHK$2.07
Beta1.44
1 Month Change5.38%
3 Month Change16.21%
1 Year Change7.69%
3 Year Change-39.13%
5 Year Change-70.78%
Change since IPO-74.21%

Recent News & Updates

Recent updates

Shareholder Returns

1951HK HealthcareHK Market
7D1.0%-0.03%2.0%
1Y7.7%-29.5%14.5%

Return vs Industry: 1951 exceeded the Hong Kong Healthcare industry which returned -29.5% over the past year.

Return vs Market: 1951 underperformed the Hong Kong Market which returned 14.5% over the past year.

Price Volatility

Is 1951's price volatile compared to industry and market?
1951 volatility
1951 Average Weekly Movement14.8%
Healthcare Industry Average Movement7.5%
Market Average Movement8.1%
10% most volatile stocks in HK Market15.5%
10% least volatile stocks in HK Market4.3%

Stable Share Price: 1951's share price has been volatile over the past 3 months compared to the Hong Kong market.

Volatility Over Time: 1951's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
19513,198Yang Dongwww.jxr-fertility.com

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.

Jinxin Fertility Group Limited Fundamentals Summary

How do Jinxin Fertility Group's earnings and revenue compare to its market cap?
1951 fundamental statistics
Market capHK$8.11b
Earnings (TTM)HK$304.07m
Revenue (TTM)HK$3.02b

26.7x

P/E Ratio

2.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1951 income statement (TTM)
RevenueCN¥2.81b
Cost of RevenueCN¥1.71b
Gross ProfitCN¥1.10b
Other ExpensesCN¥816.36m
EarningsCN¥283.10m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.10
Gross Margin39.10%
Net Profit Margin10.07%
Debt/Equity Ratio23.0%

How did 1951 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 18:43
End of Day Share Price 2025/05/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jinxin Fertility Group Limited is covered by 26 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ethan CuiBofA Global Research
Qianyi LiChina International Capital Corporation Limited
Bing ZhaoChina Renaissance Securities